Chronic obstructivve pulmonary disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) post-bronchodilator FEV1 (forced expiratory volume in first second of expiration)/ forced vital capacity (FVC) ratio was less than 0.70; (2) inform consent obtained; (3) Stable Group D COPD; (4) 1 or more moderate to severe acute exacerbations in the previous year.
Exclusion criteria
Exclusion criteria: Asthma, chronic kidney disease (CKD; stage 4 and 5), severe liver dysfunction, malignancies, psychiatric diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| moderate to severe acute exacerbations per year; | — |
Secondary
| Measure | Time frame |
|---|---|
| Direct medical cost of COPD;All-cause mortality;COPD-attributable mortality;post bronchodilator FEV1%predicted;CAT score;mMRC score; | — |
Countries
China
Contacts
Zhongshan Hospital of Fudan University